Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Gyulnara Kasumova"'
Autor:
Yi Sun, Nir Hacohen, Keith Flaherty, Ryan Sullivan, Michelle Kim, Gyulnara Kasumova, Dennie Frederick, Michael Förster, Genevieve M Boland, Ryan Park, Marijana Rucevic, Arnav Mehta, Alexis Schneider, Russell W Jenkins, William Michaud, Benchun Miao, Or-Yam Revach, Angelina Cicerchia, Amrita Kar
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/6480203bf79b44488f4a2d8ddf846143
Autor:
Xiaoling Yang, Keith Flaherty, Jun Guo, Xue Bai, Michelle Kim, Gyulnara Kasumova, Lu Si, Bixia Tang, Chuanliang Cui, Xiaoting Wei, Donald Lawrence, Christine Freedman, Riley Fadden, Krista Rubin, Tatyana Sharova, Dennie Frederick, Genevieve Boland
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 2 (2021)
Background Although the Society for Immunotherapy of Cancer (SITC) Immunotherapy Resistance Taskforce recently defined primary and secondary resistance to anti-programmed cell death protein 1 (anti-PD-1) therapy, there is lack of real-world data rega
Externí odkaz:
https://doaj.org/article/b9ec8468e1164c759afecff19f29e93a
Autor:
Xiaoling Yang, Keith Flaherty, Jun Guo, Xue Bai, Justine Cohen, Michelle Kim, Gyulnara Kasumova, Lu Si, Bixia Tang, Chuanliang Cui, Xiaoting Wei, Donald Lawrence, Christine Freedman, Riley Fadden, Krista Rubin, Tatyana Sharova, Dennie Frederick, Genevieve Boland
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/beefe4f12af54d7481d8f66693081c5a
Autor:
Xue Bai, Alexander N. Shoushtari, Allison Betof Warner, Lu Si, Bixia Tang, Chuanliang Cui, Xiaoling Yang, Xiaoting Wei, Henry T. Quach, Christopher G. Cann, Michael Z. Zhang, Lalit Pallan, Catriona Harvey, Michelle S. Kim, Gyulnara Kasumova, Tatyana Sharova, Justine V. Cohen, Donald P. Lawrence, Christine Freedman, Riley M. Fadden, Krista M. Rubin, Dennie T. Frederick, Keith T. Flaherty, Georgina V. Long, Alexander M. Menzies, Ryan J. Sullivan, Genevieve M. Boland, Douglas B. Johnson, Jun Guo
Publikováno v:
British Journal of Dermatology. 187:401-410
Background Programmed cell death receptor-1 (PD-1) monotherapy is a standard treatment for advanced cutaneous melanoma, but its efficacy and toxicity are defined in white populations and remain poorly characterized in other ethnic groups, such as Eas
Autor:
Arnav Mehta, Marijana Rucevic, Emmett Sprecher, Nir Hacohen, Genevieve Boland, Milan Parikh, Jiajia Chen, Dennie Frederick, Elliot Woods, Lynn Bi, David Lieb, Lina Hultin-Rosenberg, Jamey Guess, Ryan Park, Alexis Schneider, William Michaud, Benchun Miao, Gyulnara Kasumova, Michelle Kim, Xue Bai, Russell Jenkins, Samuel Klempner, Anna Gonye, Keren Yizhak, Moshe Sade-Feldman, David Liu, Ryan Sullivan, Keith Flaherty
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Arnav Mehta, Marijana Rucevic, Emmett Sprecher, Milan Parikh, Jiajia Chen, Dennie T. Frederick, Elliot Woods, Lynn Bi, David Lieb, Lina Hultin-Rosenberg, Jamey Guess, Ryan J. Park, Alexis Schneider, William Michaud, Benchun Miao, Gyulnara Kasumova, Michelle S. Kim, Xue Bai, Russell W. Jenkins, Samuel J. Klempner, Anna L. K. Gonye, Keren Yizhak, Moshe Sade-Feldman, David Liu, Ryan J. Sullivan, Keith T. Flaherty, Nir Hacohen, Genevieve M. Boland
Most patients treated with immune checkpoint blockade (ICB) do not have durable treatment responses. Therefore, there is a critical need to identify early non-invasive biomarkers of response. We performed plasma proteomic analysis (>700 proteins) at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e069154c91b3f99511d64bb760b67908
https://doi.org/10.1101/2022.02.02.478819
https://doi.org/10.1101/2022.02.02.478819
Neutrophils Extracellular Traps Inhibition Improves PD-1 Blockade Immunotherapy in Colorectal Cancer
Autor:
Hongji Zhang, Yujia Xia, Amblessed E. Onuma, Yu Wang, Joal D. Beane, Han Wang, Hai Huang, Meihong Deng, Jiayi He, Xiang Cheng, Zhiwei Hu, Gyulnara Kasumova, Rhea Lal, Alex C. Kim, Allan Tsung
Publikováno v:
Cancers
Cancers, Vol 13, Iss 5333, p 5333 (2021)
Volume 13
Issue 21
Cancers, Vol 13, Iss 5333, p 5333 (2021)
Volume 13
Issue 21
Immune checkpoint inhibitors can improve the prognosis of patients with advanced malignancy
however, only a small subset of advanced colorectal cancer patients in microsatellite-instability-high or mismatch-repair-deficient colorectal cancer can
however, only a small subset of advanced colorectal cancer patients in microsatellite-instability-high or mismatch-repair-deficient colorectal cancer can
Autor:
Xiaoying Liu, Konstantinos Linos, Ramya Gadde, Mikhail Lisovsky, Andrew P. Loehrer, Darcy A. Kerr, Timothy Kerrigan, Gyulnara Kasumova
Publikováno v:
Diagnostic Cytopathology. 49
Malignant gastrointestinal neuroectodermal tumor (GNET) is an extremely rare neoplasm. Immunohistochemically, GNET typically demonstrates neural differentiation but lacks melanocytic differentiation, making it distinct from clear cell sarcoma of the
Autor:
Mario, Matiotti-Neto, Mariam F, Eskander, Omidreza, Tabatabaie, Gyulnara, Kasumova, Lindsay A, Bliss, Sing Chau, Ng, Nicholas E, Tawa, Blanche, Murphy, Jonathan F, Critchlow, Jennifer F, Tseng
Publikováno v:
The American surgeon. 83(12)
The superiority of surgical cut-down of the cephalic vein versus percutaneous catheterization of the subclavian vein for the insertion of totally implantable venous access devices (TIVADs) is debated. To compare the safety and efficacy of surgical cu
Autor:
Arnav Mehta, Gyulnara Kasumova, Alvin Shi, Marijana Rucevic, Markus Sallman-Almen, Lina Hultin Rosenberg, Emmett Sprecher, Jacqueline Ohmura, Michelle Kim, David Lieb, Xue Bai, Dennie T. Frederick, Manolis Kellis, Ryan J. Sullivan, Keith T. Flaherty, Nir Hacohen, Genevieve M. Boland
Publikováno v:
Cancer Research. 79:4533-4533
Immune checkpoint blockade (ICB) has revolutionized the treatment of many solid tumors, including metastatic melanoma. Despite recent successes, many patients fail to respond or are overcome by severe toxicities that limit further treatment. To date,